Chemed (NYSE:CHE) CEO Kevin Mcnamara Sells 2,000 Shares of Stock

Chemed Corporation (NYSE:CHE) CEO Kevin Mcnamara sold 2,000 shares of the company’s stock in a transaction on Thursday, March 12th. The stock was sold at an average price of $403.18, for a total value of $806,360.00. Following the sale, the chief executive officer owned 93,719 shares of the company’s stock, valued at $37,785,626.42. This trade represents a 2.09% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.

Chemed Trading Up 0.6%

Shares of NYSE:CHE opened at $402.03 on Friday. The stock’s fifty day simple moving average is $441.48 and its two-hundred day simple moving average is $440.96. Chemed Corporation has a 1-year low of $385.00 and a 1-year high of $623.60. The stock has a market cap of $5.54 billion, a PE ratio of 21.89, a price-to-earnings-growth ratio of 1.58 and a beta of 0.46.

Chemed (NYSE:CHE) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $6.42 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $7.02 by ($0.60). The firm had revenue of $639.34 million for the quarter, compared to analysts’ expectations of $659.09 million. Chemed had a return on equity of 25.66% and a net margin of 10.48%.Chemed’s revenue was down .1% compared to the same quarter last year. During the same period in the prior year, the firm earned $6.83 earnings per share. Chemed has set its FY 2026 guidance at 23.250-24.250 EPS. On average, sell-side analysts forecast that Chemed Corporation will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 13th. Shareholders of record on Monday, February 23rd were given a $0.60 dividend. This represents a $2.40 dividend on an annualized basis and a yield of 0.6%. The ex-dividend date of this dividend was Monday, February 23rd. Chemed’s dividend payout ratio is presently 13.06%.

Institutional Trading of Chemed

Several hedge funds have recently added to or reduced their stakes in CHE. Monetary Solutions Ltd purchased a new stake in shares of Chemed during the 4th quarter worth approximately $25,000. Los Angeles Capital Management LLC bought a new stake in shares of Chemed in the 4th quarter worth approximately $26,000. Smartleaf Asset Management LLC lifted its stake in Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. purchased a new position in Chemed in the fourth quarter valued at approximately $27,000. Finally, First Horizon Corp bought a new position in Chemed during the third quarter valued at $31,000. Institutional investors own 95.85% of the company’s stock.

Wall Street Analyst Weigh In

CHE has been the topic of several recent analyst reports. Jefferies Financial Group cut shares of Chemed from a “buy” rating to a “hold” rating in a research report on Thursday, January 22nd. Oppenheimer reduced their target price on Chemed from $580.00 to $500.00 and set an “outperform” rating for the company in a report on Friday, February 27th. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Chemed in a research report on Wednesday, January 21st. Royal Bank Of Canada reiterated a “sector perform” rating and set a $422.00 price target (down from $572.00) on shares of Chemed in a report on Friday, February 27th. Finally, Zacks Research downgraded Chemed from a “hold” rating to a “strong sell” rating in a research note on Wednesday, March 4th. Two equities research analysts have rated the stock with a Buy rating, three have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, Chemed currently has a consensus rating of “Hold” and an average target price of $498.00.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.